Duke Faculty-Proposed Voucher System helping Impact Investors Address Global Health
A new treatment to help eliminate a neglected tropical disease was developed thanks in part to an incentive program devised by researchers at Duke University. The U.S. Food and Drug Administration has approved moxidectin, a drug developed by non-profit biopharmaceutical company Medicines Development for Global Health. Moxidectin treats river blindness, a parasitic infection that affects Read more about Duke Faculty-Proposed Voucher System helping Impact Investors Address Global Health[…]